Clinical Trial Update: Contribution of F18-FDG PET/CT to the Early Assessment of Pazopanib Therapy Efficacy in Advanced Soft Tissue Sarcoma

View source ↗

Summary

This clinical trial update evaluates the contribution of F18-FDG PET/CT for early assessment of pazopanib efficacy in patients with advanced soft tissue sarcoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Votrient (Pazopanib)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Soft Tissue Sarcoma (STS) | Status: UNKNOWN